US Stock MarketDetailed Quotes

Fulcrum Therapeutics (FULC)

Watchlist
  • 11.050
  • +0.630+6.05%
Close Jan 22 16:00 ET
728.97MMarket Cap-9.69P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fulcrum Therapeutics (FULC) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
25.60%-14.19M
-123.46%-13.82M
39.66%-15.26M
97.56%-2.22M
27.62%-16.76M
16.74%-19.07M
383.37%58.9M
-4.84%-25.28M
6.27%-90.97M
-17.58%-23.16M
Net income from continuing operations
9.68%-19.6M
-131.22%-17.3M
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
Depreciation and amortization
-6.23%346K
-8.51%344K
-26.30%353K
-26.66%1.59M
-27.36%369K
-30.51%369K
-33.69%376K
-15.37%479K
-10.02%2.17M
-14.04%508K
Change In working capital
657.32%2.29M
1,497.92%1.34M
86.47%-223K
7.91%-4.25M
-103.10%-2.09M
73.92%-410K
-112.31%-96K
40.93%-1.65M
-49.10%-4.61M
-132.43%-1.03M
-Change in receivables
--0
141.96%979K
108.01%1.12M
-406.17%-1.56M
3,527.91%1.56M
-1,840.79%-1.32M
-318.85%-2.33M
313.08%537K
-109.04%-308K
-92.51%43K
-Change in prepaid assets
101.82%44K
-162.20%-288K
128.14%1.83M
-27.33%-1.37M
66.72%-207K
-250.29%-2.42M
-39.40%463K
253.83%803K
-530.59%-1.07M
-181.20%-622K
-Change in payables and accrued expense
52.25%2.43M
-57.05%831K
-6.24%-3M
-56.44%-2.63M
-3,727.17%-3.34M
369.48%1.6M
107.17%1.94M
-33.63%-2.82M
-170.21%-1.68M
-96.27%92K
-Change in other current assets
-99.84%3K
-100.00%-2K
--0
2,028.72%2M
414.29%66K
38,160.00%1.91M
-102.78%-1K
-68.92%23K
106.02%94K
-250.00%-21K
-Change in other working capital
-12.07%-195K
-11.25%-178K
7.89%-175K
57.55%-700K
66.35%-176K
52.72%-174K
59.70%-160K
47.37%-190K
60.26%-1.65M
15.65%-523K
Cash from discontinued investing activities
Operating cash flow
25.60%-14.19M
-123.46%-13.82M
39.66%-15.26M
97.56%-2.22M
27.62%-16.76M
16.74%-19.07M
383.37%58.9M
-4.84%-25.28M
6.27%-90.97M
-17.58%-23.16M
Investing cash flow
Cash flow from continuing investing activities
327.86%18.61M
211.39%13.93M
-102.04%-777K
187.84%32.23M
-87.69%2.26M
-77.13%4.35M
-162.93%-12.51M
140.59%38.13M
-395.59%-36.69M
150.48%18.35M
Net PPE purchase and sale
-373.68%-90K
---65K
--0
45.28%-278K
-200.00%-231K
70.77%-19K
--0
83.63%-28K
74.12%-508K
33.62%-77K
Net investment purchase and sale
328.06%18.7M
211.91%14M
-102.04%-777K
189.84%32.51M
-86.48%2.49M
-77.11%4.37M
-162.32%-12.51M
140.69%38.16M
-351.70%-36.18M
150.85%18.43M
Cash from discontinued investing activities
Investing cash flow
327.86%18.61M
211.39%13.93M
-102.04%-777K
187.84%32.23M
-87.69%2.26M
-77.13%4.35M
-162.93%-12.51M
140.59%38.13M
-395.59%-36.69M
150.48%18.35M
Financing cash flow
Cash flow from continuing financing activities
-89.92%64K
-20.16%301K
0
-97.68%2.75M
-71.08%83K
635K
165.49%377K
-98.60%1.65M
40.08%118.12M
31.65%287K
Net common stock issuance
----
----
----
--0
--0
--0
--0
--0
45.22%117.35M
--0
Proceeds from stock option exercised by employees
-89.92%64K
-20.16%301K
--0
253.41%2.75M
-71.08%83K
--635K
165.49%377K
374.43%1.65M
-77.92%777K
7.49%287K
Cash from discontinued financing activities
Financing cash flow
-89.92%64K
-20.16%301K
--0
-97.68%2.75M
-71.08%83K
--635K
165.49%377K
-98.60%1.65M
40.08%118.12M
31.65%287K
Net cash flow
Beginning cash position
-50.19%43.79M
5.42%43.38M
122.90%59.41M
-26.35%26.66M
136.85%73.83M
150.78%87.92M
14.86%41.15M
-26.35%26.66M
-0.86%36.19M
-66.13%31.17M
Current changes in cash
131.84%4.49M
-99.11%414K
-210.62%-16.03M
443.56%32.76M
-219.19%-14.42M
-262.51%-14.09M
6,189.58%46.77M
4,082.14%14.5M
-2,936.62%-9.54M
91.91%-4.52M
End cash Position
-34.61%48.28M
-50.19%43.79M
5.42%43.38M
122.90%59.41M
122.90%59.41M
136.85%73.83M
150.78%87.92M
14.86%41.15M
-26.35%26.66M
-26.35%26.66M
Free cash flow
25.20%-14.28M
-123.57%-13.89M
39.72%-15.26M
97.27%-2.5M
26.87%-16.99M
16.89%-19.09M
380.74%58.9M
-4.22%-25.31M
7.62%-91.47M
-17.28%-23.24M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 25.60%-14.19M-123.46%-13.82M39.66%-15.26M97.56%-2.22M27.62%-16.76M16.74%-19.07M383.37%58.9M-4.84%-25.28M6.27%-90.97M-17.58%-23.16M
Net income from continuing operations 9.68%-19.6M-131.22%-17.3M34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M
Depreciation and amortization -6.23%346K-8.51%344K-26.30%353K-26.66%1.59M-27.36%369K-30.51%369K-33.69%376K-15.37%479K-10.02%2.17M-14.04%508K
Change In working capital 657.32%2.29M1,497.92%1.34M86.47%-223K7.91%-4.25M-103.10%-2.09M73.92%-410K-112.31%-96K40.93%-1.65M-49.10%-4.61M-132.43%-1.03M
-Change in receivables --0141.96%979K108.01%1.12M-406.17%-1.56M3,527.91%1.56M-1,840.79%-1.32M-318.85%-2.33M313.08%537K-109.04%-308K-92.51%43K
-Change in prepaid assets 101.82%44K-162.20%-288K128.14%1.83M-27.33%-1.37M66.72%-207K-250.29%-2.42M-39.40%463K253.83%803K-530.59%-1.07M-181.20%-622K
-Change in payables and accrued expense 52.25%2.43M-57.05%831K-6.24%-3M-56.44%-2.63M-3,727.17%-3.34M369.48%1.6M107.17%1.94M-33.63%-2.82M-170.21%-1.68M-96.27%92K
-Change in other current assets -99.84%3K-100.00%-2K--02,028.72%2M414.29%66K38,160.00%1.91M-102.78%-1K-68.92%23K106.02%94K-250.00%-21K
-Change in other working capital -12.07%-195K-11.25%-178K7.89%-175K57.55%-700K66.35%-176K52.72%-174K59.70%-160K47.37%-190K60.26%-1.65M15.65%-523K
Cash from discontinued investing activities
Operating cash flow 25.60%-14.19M-123.46%-13.82M39.66%-15.26M97.56%-2.22M27.62%-16.76M16.74%-19.07M383.37%58.9M-4.84%-25.28M6.27%-90.97M-17.58%-23.16M
Investing cash flow
Cash flow from continuing investing activities 327.86%18.61M211.39%13.93M-102.04%-777K187.84%32.23M-87.69%2.26M-77.13%4.35M-162.93%-12.51M140.59%38.13M-395.59%-36.69M150.48%18.35M
Net PPE purchase and sale -373.68%-90K---65K--045.28%-278K-200.00%-231K70.77%-19K--083.63%-28K74.12%-508K33.62%-77K
Net investment purchase and sale 328.06%18.7M211.91%14M-102.04%-777K189.84%32.51M-86.48%2.49M-77.11%4.37M-162.32%-12.51M140.69%38.16M-351.70%-36.18M150.85%18.43M
Cash from discontinued investing activities
Investing cash flow 327.86%18.61M211.39%13.93M-102.04%-777K187.84%32.23M-87.69%2.26M-77.13%4.35M-162.93%-12.51M140.59%38.13M-395.59%-36.69M150.48%18.35M
Financing cash flow
Cash flow from continuing financing activities -89.92%64K-20.16%301K0-97.68%2.75M-71.08%83K635K165.49%377K-98.60%1.65M40.08%118.12M31.65%287K
Net common stock issuance --------------0--0--0--0--045.22%117.35M--0
Proceeds from stock option exercised by employees -89.92%64K-20.16%301K--0253.41%2.75M-71.08%83K--635K165.49%377K374.43%1.65M-77.92%777K7.49%287K
Cash from discontinued financing activities
Financing cash flow -89.92%64K-20.16%301K--0-97.68%2.75M-71.08%83K--635K165.49%377K-98.60%1.65M40.08%118.12M31.65%287K
Net cash flow
Beginning cash position -50.19%43.79M5.42%43.38M122.90%59.41M-26.35%26.66M136.85%73.83M150.78%87.92M14.86%41.15M-26.35%26.66M-0.86%36.19M-66.13%31.17M
Current changes in cash 131.84%4.49M-99.11%414K-210.62%-16.03M443.56%32.76M-219.19%-14.42M-262.51%-14.09M6,189.58%46.77M4,082.14%14.5M-2,936.62%-9.54M91.91%-4.52M
End cash Position -34.61%48.28M-50.19%43.79M5.42%43.38M122.90%59.41M122.90%59.41M136.85%73.83M150.78%87.92M14.86%41.15M-26.35%26.66M-26.35%26.66M
Free cash flow 25.20%-14.28M-123.57%-13.89M39.72%-15.26M97.27%-2.5M26.87%-16.99M16.89%-19.09M380.74%58.9M-4.22%-25.31M7.62%-91.47M-17.28%-23.24M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -